Compare AZO & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AZO | EW |
|---|---|---|
| Founded | 1979 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.4B | 50.2B |
| IPO Year | 1998 | 1999 |
| Metric | AZO | EW |
|---|---|---|
| Price | $3,725.42 | $85.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 21 |
| Target Price | ★ $4,308.80 | $96.47 |
| AVG Volume (30 Days) | 124.4K | ★ 4.6M |
| Earning Date | 06-02-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 31.04 | 1.83 |
| Revenue | ★ $18,938,717,000.00 | $6,067,600,000.00 |
| Revenue This Year | $9.64 | $13.39 |
| Revenue Next Year | $7.47 | $9.78 |
| P/E Ratio | $119.67 | ★ $46.57 |
| Revenue Growth | 2.43 | ★ 11.55 |
| 52 Week Low | $3,210.72 | $65.94 |
| 52 Week High | $4,388.11 | $87.89 |
| Indicator | AZO | EW |
|---|---|---|
| Relative Strength Index (RSI) | 50.46 | 55.49 |
| Support Level | $3,576.67 | $81.61 |
| Resistance Level | $3,861.39 | $87.22 |
| Average True Range (ATR) | 104.84 | 2.16 |
| MACD | -10.88 | 0.28 |
| Stochastic Oscillator | 47.01 | 73.61 |
AutoZone operates as a leading retailer of aftermarket automotive parts in the United States. The firm operates 6,666 stores domestically, serving the do-it-yourself and commercial (do-it-for-me) end markets. Through its vast store footprint and distribution network, AutoZone manages a wide array of stock-keeping units applicable to numerous vehicle makes and models, providing its consumers with ample product availability. The firm drives traffic by providing superior and convenient customer service as AutoZone's team of knowledgeable staff assists consumers with diagnosing a vehicle's problem, selecting the necessary part for replacement, and occasionally, installation. The company also operates internationally, with 895 stores in Mexico and 149 in Brazil.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.